Skip to content
The Nexus
DossierENTITY

Sun Pharma

Coverage of Sun Pharma in the Nexus archive.

Earliest in view: Apr 16 · 05:46 UTCMost recent: May 6 · 01:00 UTC
Co-mentioned in this coverage
Organonorganization3Eli Lillyorganization1healthcare dealstopic1Paul O'Driscollperson1Grünenthalorganization1Blood pressuretopic1
Recent coverage
  • BUSINESSMay 6 · 01:00 UTCBLOOMBERG
    Sun Pharma Explores Funding Mix for $12 Billion Organon Deal

    Sun Pharma is exploring funding options for its $12 billion deal to acquire Organon. The deal is a significant investment for Sun Pharma and requires careful consideration of funding sources. The company is weighing its options to secure the necessary funds.

  • HEALTHApr 29 · 18:27 UTCBLOOMBERG
    Sun Pharma, Lilly Lead Latest Healthcare Deal Rush

    Sun Pharma and Eli Lilly are leading recent healthcare deals, indicating increased activity in the sector. The article highlights their prominent roles in the latest wave of healthcare industry mergers and partnerships.

  • BUSINESSApr 27 · 00:19 UTCBLOOMBERG
    Sun Pharma to Acquire US-Listed Organon in $12 Billion Deal

    Sun Pharma is set to acquire US-listed Organon in a $12 billion deal. The transaction marks a significant expansion for Sun Pharma in the pharmaceutical sector.

  • BUSINESSApr 16 · 05:46 UTCBLOOMBERG
    Sun Pharma, Grünenthal Are Said to Vie for US-Listed Organon

    Sun Pharma and Grünenthal are reportedly competing to acquire US-listed pharmaceutical company Organon. The news highlights potential strategic moves in the pharmaceutical sector.